chevron_leftBack
As of 7 June 2026, Abbott India Ltd. has a market cap of $5.66B USD, ranking #3436 globally and #191 in India.
It ranks #253 in the Healthcare sector, and #98 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$5.66BUSD
541.53B INR
Enterprise Value
$5.45BUSD
519.93B INR
Revenue (TTM)
$712.69MUSD
68.24B INR
EBITDA (TTM)
$188.62MUSD
17.99B INR
Net Income (TTM)
$159.18MUSD
15.24B INR
EBITDA Margin
26%
Profit Margin
22%
PE Ratio
35.5
Forward PE
32.2
PS Ratio
7.9
PB Ratio
13.5
EV/EBITDA
28.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kartik Rajendran
open_in_new
Employees
3,659
Founded
1910
Website
abbott.co.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 0.2% | -2.5% | -7.7% | -14% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ABBOTINDIA
Abbott India Ltd
ISIN: INE358A01014
Shares Out.:
Shares Outstanding:
21.249M1
Shares Float:
5.203M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25,435.00 INR | |
|
500488
(ABBOTINDIA)
Abbott India Ltd
ISIN: INE358A01014
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25,484.55 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Abbott India Ltd.
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$44.57B
688%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.12B
220%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$14.95B
164%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.57B
105%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.73B
72%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.57B
69%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
13K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
10K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
6K%
|
97.4
|
|
SIX: RO
|
$324.68B
6K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
5K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
5K%
218.9B CHF
|
20.5
|
chevron_leftBack